MedTrace Logo

Melatonin Effects on Sleep and Circadian Rhythm in Youth and Young Adults With At-risk Symptoms

NCT03826563 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2023-05-09

No results posted yet for this study

Summary

Randomized control trial assessing supplemental melatonin for youth with at-risk or psychotic symptoms.

Conditions

Interventions

DRUG

oral melatonin tablets (NatureMade brand)

melatonin tablets

OTHER

Placebo

pill placebo

Sponsors & Collaborators

Principal Investigators

  • Raquel Gur, MD · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-18
Primary Completion
2023-04-07
Completion
2023-04-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826563 on ClinicalTrials.gov